LncRNA-AP001631.9 promotes cell migration in gastric cancer

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 6, 2015, Pages 6235-6244

  Cai, Hui ^a   Ye, Xiaojuan ^a   He, Bin ^a   Li, Qiang ^a   Li, Yandong ^a   Gao, Yong ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cell migration; FoxM1; Gastric cancer; LncRNA

Indexed keywords

FORKHEAD BOX PROTEIN M1; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, HUMAN; LONG UNTRANSLATED RNA; SMALL INTERFERING RNA; TUMOR MARKER;

ANIMAL; BIOSYNTHESIS; CELL MOTION; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; MALE; MOUSE; NUDE MOUSE; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION; XENOGRAFT;

ANIMALS; BIOMARKERS, TUMOR; CELL LINE, TUMOR; CELL MOVEMENT; FORKHEAD BOX PROTEIN M1; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, LONG NONCODING; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION;

EID: 84938633468     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Yamamoto H, Watanabe Y, Maehata T, Morita R, Yoshida Y, Oikawa R, Ishigooka S, Ozawa S, Matsuo Y, Hosoya K, Yamashita M, Taniguchi H, Nosho K, Suzuki H, Yasuda H, Shinomura Y and Itoh F. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa. World J Gastroenterol 2014; 20: 3927-3937.
2. Jemal A, Siegel R, Xu J and Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
3. Duraes C, Almeida GM, Seruca R, Oliveira C and Carneiro F. Biomarkers for gastric cancer: prognostic, predictive or targets of therapy? Virchows Arch 2014; 464: 367-378.
4. Wang XN and Liang H. Some problems in the surgical treatment of gastric cancer. Chin J Cancer 2010; 29: 369-373.
5. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S and Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44: 1345-1389.
6. Vogiatzi P, Vindigni C, Roviello F, Renieri A and Giordano A. Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis. J Cell Physiol 2007; 211: 287-295.
7. Pinheiro H, Bordeira-Carrico R, Seixas S, Carvalho J, Senz J, Oliveira P, Inacio P, Gusmao L, Rocha J, Huntsman D, Seruca R and Oliveira C. Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum Mol Genet 2010; 19: 943-952.
8. Tahira AC, Kubrusly MS, Faria MF, Dazzani B, Fonseca RS, Maracaja-Coutinho V, Verjovski-Almeida S, Machado MC and Reis EM. Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer. Mol Cancer 2011; 10: 141.
9. Rinn JL and Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem 2012; 81: 145-166.
10. Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet 2009; 5: e1000459.
11. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861-874.
12. Qi P, Xu MD, Ni SJ, Huang D, Wei P, Tan C, Zhou XY and Du X. Low expression of LOC285194 is associated with poor prognosis in colorectal cancer. J Transl Med 2013; 11: 122.
13. Sanchez Y and Huarte M. Long non-coding RNAs: challenges for diagnosis and therapies. Nucleic Acid Ther 2013; 23: 15-20.
14. Wierstra I and Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem 2007; 388: 1257-1274.
15. Teh MT, Wong ST, Neill GW, Ghali LR, Philpott MP and Quinn AG. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res 2002; 62: 4773-4780.
16. Lam EW, Brosens JJ, Gomes AR and Koo CY. Forkhead box proteins: tuning forks for tran scriptional harmony. Nat Rev Cancer 2013; 13: 482-495.
17. Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, Tan Y, Ackerson T and Costa RH. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol 2005; 25: 10875-10894.
18. Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, Morrison A, Clevers H and Medema RH. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol 2005; 7: 126-136.
19. Chan DW, Yu SY, Chiu PM, Yao KM, Liu VW, Cheung AN and Ngan HY. Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis. J Pathol 2008; 215: 245-252.
20. Uddin S, Ahmed M, Hussain A, Abubaker J, Al-Sanea N, AbdulJabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Jehan Z, Bavi P, Siraj AK and Al-Kuraya KS. Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy. Am J Pathol 2011; 178: 537-547.
21. Li Q, Zhang N, Jia Z, Le X, Dai B, Wei D, Huang S, Tan D and Xie K. Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res 2009; 69: 3501-3509.
22. Gibb EA, Brown CJ and Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011; 10: 38.